MarketCap
Facebook
X
TelegramAnnual report 2025
added 02-17-2026
Accuray Incorporated Operating Income 2011-2026 | ARAY
Operating profit (also called operating income or profit from core activities) is a financial metric that reflects a company's profit from its main operational activities before interest expenses and taxes are taken into account.
FormulaOperating profit = Revenue – Operating expensesFeatures of the metric
- Evaluates business efficiency
Shows how well the company controls its production and administrative costs. - Independent of financial structure
Excludes the impact of debt burden (interest) and taxes, allowing objective comparison of companies. - Main source for growth
High operating profit provides resources for investments, business expansion, and increased competitiveness.
If a company shows strong operating profit, it signals to investors that the core business is operating efficiently, even if net profit is temporarily reduced due to debt or tax burden.
Annual Operating Income Accuray Incorporated
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 7.84 M | 504 K | 2.38 M | 8.15 M | 22.2 M | 12.5 M | 583 K | -3.8 M | -9.82 M | -4.87 M | -19.2 M | -18.1 M | -80.7 M | -56.2 M | -27.8 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 22.2 M | -80.7 M | -11.1 M |
Quarterly Operating Income Accuray Incorporated
| 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -11.6 M | -11.3 M | - | 1.05 M | 4.71 M | -2.15 M | - | -4.56 M | -3.96 M | 2.21 M | - | 2.32 M | 2.7 M | -2.18 M | 523 K | -292 K | 3.98 M | 2.41 M | 6.39 M | 4.43 M | 8.2 M | 5.47 M | 8.2 M | 5.47 M | 3.62 M | -4.28 M | 3.62 M | -4.28 M | -868 K | -4.69 M | -868 K | -4.69 M | -1.02 M | -2.05 M | -1.02 M | -2.05 M | -4.82 M | -6.55 M | -4.82 M | -6.55 M | -124 K | -7.23 M | -124 K | -7.23 M | -3.59 M | -15.3 M | -3.59 M | -15.3 M | -716 K | -12.3 M | -716 K | -12.3 M | -22.3 M | -20.6 M | -22.3 M | -34.9 M | -5.45 M | -24.7 M | -7.31 M | -24.7 M |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 8.2 M | -34.9 M | -4.56 M |
Operating Income of other stocks in the Medical devices industry
| Issuer | Operating Income | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Acutus Medical
AFIB
|
-11.7 M | - | -26.83 % | $ 2.62 M |  USA |
 |
AdaptHealth Corp.
AHCO
|
90.9 M | $ 12.07 | 0.33 % | $ 1.63 B | USA |
 |
Allied Healthcare Products
AHPI
|
-1.27 M | - | 3.58 % | $ 2.21 M | USA |
 |
EDAP TMS S.A.
EDAP
|
-19.8 M | $ 3.45 | 1.77 % | $ 129 M |  France |
 |
Apollo Endosurgery
APEN
|
-31.4 M | - | - | $ 475 M | USA |
 |
Avinger
AVGR
|
-16.6 M | - | -20.74 % | $ 369 K | USA |
 |
Align Technology
ALGN
|
608 M | $ 171.87 | 0.74 % | $ 12.9 B | USA |
 |
AxoGen
AXGN
|
-7.85 M | $ 32.64 | -5.23 % | $ 1.5 B | USA |
 |
Axonics Modulation Technologies
AXNX
|
-64.9 M | - | - | $ 3.31 B | USA |
 |
Aziyo Biologics
AZYO
|
-26.9 M | - | 1.37 % | $ 20.5 M | USA |
 |
Neovasc
NVCN
|
-31.1 M | - | - | $ 111 M |  Canada |
 |
Butterfly Network
BFLY
|
-74.4 M | $ 4.13 | 0.49 % | $ 874 M | USA |
 |
BIOLASE
BIOL
|
-17.9 M | - | -13.19 % | $ 166 K | USA |
 |
Bruker Corporation
BRKR
|
253 M | $ 36.74 | -0.05 % | $ 5.47 K | USA |
 |
BioSig Technologies
BSGM
|
-71.1 M | - | 37.08 % | $ 85.7 M | USA |
 |
Boston Scientific Corporation
BSX
|
3.61 B | $ 62.59 | -0.37 % | $ 92.7 B | USA |
 |
Alphatec Holdings
ATEC
|
-82.1 M | $ 10.97 | 1.29 % | $ 1.65 B | USA |
 |
CONMED Corporation
CNMD
|
103 M | - | - | $ 1.06 B | USA |
 |
Conformis
CFMS
|
-46.3 M | - | - | $ 16.4 M | USA |
 |
ClearPoint Neuro
CLPT
|
-24.2 M | $ 9.38 | 0.11 % | $ 266 M | USA |
 |
Cardiovascular Systems
CSII
|
-35.8 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
-14.7 M | $ 0.59 | 1.2 % | $ 36.7 M | USA |
 |
Cutera
CUTR
|
-156 M | - | -10.19 % | $ 1.99 M | USA |
 |
Delcath Systems
DCTH
|
660 K | $ 9.7 | 0.73 % | $ 347 M | USA |
 |
Dynatronics Corporation
DYNT
|
-2.45 M | - | 14.99 % | $ 929 K | USA |
 |
Eargo
EAR
|
-112 M | - | - | $ 10.2 M | USA |
 |
Edwards Lifesciences Corporation
EW
|
1.26 B | $ 81.19 | 0.17 % | $ 47.5 B | USA |
 |
Second Sight Medical Products
EYES
|
-27.6 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
9.66 M | $ 23.61 | 1.37 % | $ 200 M | USA |
 |
FONAR Corporation
FONR
|
5.31 M | $ 18.6 | 0.05 % | $ 122 M | USA |
 |
Globus Medical
GMED
|
480 M | $ 88.6 | 0.77 % | $ 12 B | USA |
 |
Helius Medical Technologies
HSDT
|
-12.4 M | $ 1.9 | 2.15 % | $ 1.15 M | USA |
 |
Integra LifeSciences Holdings Corporation
IART
|
28.4 M | $ 9.31 | -2.31 % | $ 717 M | USA |
 |
Inogen
INGN
|
-30.2 M | $ 6.36 | 2.42 % | $ 169 M | USA |
 |
Inspire Medical Systems
INSP
|
51 M | $ 54.14 | -1.55 % | $ 1.59 B | USA |
 |
IRIDEX Corporation
IRIX
|
-2.57 M | $ 1.0 | 1.66 % | $ 16.9 M | USA |
 |
IRadimed Corporation
IRMD
|
26.1 M | $ 95.66 | -0.59 % | $ 1.22 B | USA |
 |
Integer Holdings Corporation
ITGR
|
221 M | $ 85.63 | -1.4 % | $ 2.97 B | USA |
 |
Invacare Corporation
IVC
|
-80.5 M | - | - | $ 24.7 M | USA |
 |
GBS
GBS
|
-10.6 M | - | -0.57 % | $ 7.12 M | USA |